Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP245013.RARATxhqJrGkyU6u-kLWfJP--Cbl6nYo4DeP1IcaT-P5c130_assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP245013.RARATxhqJrGkyU6u-kLWfJP--Cbl6nYo4DeP1IcaT-P5c130_provenance.
• NP1175992.RAAdKwaZftN5VC8GJ4LI8kNhgx09VCE4PhO_G-yHJKVhg130_assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1175992.RAAdKwaZftN5VC8GJ4LI8kNhgx09VCE4PhO_G-yHJKVhg130_provenance.
• NP546169.RA4iIVF4E8PP0_JpYM92hAB-v7o11KqSYiuo_G9WlaZso130_assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP546169.RA4iIVF4E8PP0_JpYM92hAB-v7o11KqSYiuo_G9WlaZso130_provenance.
• NP419914.RAVasJgHvr2RBkLTLYPa1217nIBs2k7eUEOT5wNnYuURk130_assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419914.RAVasJgHvr2RBkLTLYPa1217nIBs2k7eUEOT5wNnYuURk130_provenance.
• NP546201.RAf3iUEYThuXZFZDjaJPymOBAiSHHCaIuaomdAdfkb7Z0130_assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP546201.RAf3iUEYThuXZFZDjaJPymOBAiSHHCaIuaomdAdfkb7Z0130_provenance.
• assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1175986.RA2kY7PGKtqza9XwFcXskTvYtd-XPkGeUJvfY65eBNRQs130_assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1175986.RA2kY7PGKtqza9XwFcXskTvYtd-XPkGeUJvfY65eBNRQs130_provenance.
• NP1175988.RA0WeYnbCxUEbmRk-R-K7X_6C4p9IK7v98x6i2gifOKo0130_assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1175988.RA0WeYnbCxUEbmRk-R-K7X_6C4p9IK7v98x6i2gifOKo0130_provenance.
• NP1175989.RA3VcPpdhGg0jQQfjLyLb5ImegsmaEhh_mhW1aIMAwByo130_assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1175989.RA3VcPpdhGg0jQQfjLyLb5ImegsmaEhh_mhW1aIMAwByo130_provenance.
• NP246094.RAMsSi5f-pNkd1rdnsUlkBA4HHlrAEcQAQjyeDrCxuXAI130_assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP246094.RAMsSi5f-pNkd1rdnsUlkBA4HHlrAEcQAQjyeDrCxuXAI130_provenance.
• NP321518.RALjV37tHEAgEBYZuil8NXyhh3Ky02UrTppzDmCRzCdXQ130_assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321518.RALjV37tHEAgEBYZuil8NXyhh3Ky02UrTppzDmCRzCdXQ130_provenance.
• NP322019.RAOf6US8TuT-6dNd5M9IptU1jDHqSNJhrB_zor1GJOXIk130_assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP322019.RAOf6US8TuT-6dNd5M9IptU1jDHqSNJhrB_zor1GJOXIk130_provenance.
• NP1175987.RAYngcrIR8PNLKWbxgx6VRYjzSG-qfRexc0ePnMLsKrkA130_assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1175987.RAYngcrIR8PNLKWbxgx6VRYjzSG-qfRexc0ePnMLsKrkA130_provenance.
• assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP419833.RAIzXHDyucfuEurTVSGVM7AkM9zPFVGVqxTFKeKcl_PpU130_assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419833.RAIzXHDyucfuEurTVSGVM7AkM9zPFVGVqxTFKeKcl_PpU130_provenance.
• NP545982.RAOJCNLFracZpUmSO3lAQJBH9_BX0F4HORgvEBnGt_KRs130_assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP545982.RAOJCNLFracZpUmSO3lAQJBH9_BX0F4HORgvEBnGt_KRs130_provenance.
• NP1175984.RAKpMxpsnFHGug7mE6DfERVbp6zZPYlEBVtgORk0eyFB4130_assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1175984.RAKpMxpsnFHGug7mE6DfERVbp6zZPYlEBVtgORk0eyFB4130_provenance.
• NP1175990.RAJ0CnqB_oyd6qw5VF34jrotx4NTcGyuS1VEb-HzvNHg4130_assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1175990.RAJ0CnqB_oyd6qw5VF34jrotx4NTcGyuS1VEb-HzvNHg4130_provenance.
• NP1175993.RAFzvbolLYw1nLT_vmDGLCyT5joNvZN2ufu5vatZupjUY130_assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1175993.RAFzvbolLYw1nLT_vmDGLCyT5joNvZN2ufu5vatZupjUY130_provenance.
• NP321956.RAlGWHo1DcBGOrMtcO4QIXJxQZd1kILv7uKi8jj3d3TDo130_assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321956.RAlGWHo1DcBGOrMtcO4QIXJxQZd1kILv7uKi8jj3d3TDo130_provenance.
• NP419908.RAjBXL_B3puGw6f5_k_NC-F5zKCoA1tXApsdQFKFXaEEE130_assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419908.RAjBXL_B3puGw6f5_k_NC-F5zKCoA1tXApsdQFKFXaEEE130_provenance.
• NP1175985.RAqJvlourhvDZa4DOD1G9Vj-dv1mT6LBlI3XETiokBI5A130_assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1175985.RAqJvlourhvDZa4DOD1G9Vj-dv1mT6LBlI3XETiokBI5A130_provenance.
• NP1175991.RAtrnUm9H-cEdi7_HAHyqpJclRUsddMO_1QAhRWYFLTa0130_assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1175991.RAtrnUm9H-cEdi7_HAHyqpJclRUsddMO_1QAhRWYFLTa0130_provenance.
• NP1175994.RAvZJapM1Kozv8bjhXx0ja-x1ce97txFnhYq5nTxpiQqo130_assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1175994.RAvZJapM1Kozv8bjhXx0ja-x1ce97txFnhYq5nTxpiQqo130_provenance.
• NP1175995.RAm1bqxywdhiDULpFUhG993Kp9WItcmrQp6n0WubGzbL4130_assertion description "[In addition, genetic variation in the apolipoprotein E (APOE), catechol-O-methyltransferase (COMT), microtubule-associated protein tau (MAPT), and glucocerebrosidase (GBA) genes may confer risk for cognitive impairment in PD; and gait disturbance may also indicate an increased risk for dementia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1175995.RAm1bqxywdhiDULpFUhG993Kp9WItcmrQp6n0WubGzbL4130_provenance.